Endoluminal Therapy for Esophageal Disease: An Introduction

Gastrointestinal Endoscopy Clinics of North America

Volumn 20, Issue 1, 2010, Pages 1-10

  Wolfsen, Herbert C ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Argon plasma coagulation; Barrett esophagus; Cryotherapy; Dysplasia; Endoscopic mucosal resection; Multipolar electrocoagulation; Photodynamic therapy; Radiofrequency ablation

Indexed keywords

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; COLON ADENOMA; COLORECTAL CARCINOMA; CRYOTHERAPY; DISEASE COURSE; DUODENOGASTRIC REFLUX; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL DYSPLASIA; ESOPHAGOSCOPY; ESOPHAGUS DISEASE; ESOPHAGUS RESECTION; HUMAN; MEDICAL RESEARCH; PHOTODYNAMIC THERAPY; PREVALENCE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; RISK REDUCTION;

ADENOCARCINOMA; ADENOMA; BARRETT ESOPHAGUS; CARCINOMA; COLONIC NEOPLASMS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; PRECANCEROUS CONDITIONS; RECTAL NEOPLASMS; RISK ASSESSMENT;

EID: 70749089496     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.giec.2009.07.006     Document Type: Review

References (84)

1. Wolfsen H.C. Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia. Expert Rev Med Devices 2 6 (2005) 713-723
2. Spechler S.J. Clinical practice. Barrett's Esophagus. N Engl J Med 346 11 (2002) 836-842
3. Peters J.H., Hagen J.A., and DeMeester S.R. Barrett's esophagus. J Gastrointest Surg 8 1 (2004) 1-17
4. Eisen G.M. Ablation therapy for Barrett's esophagus. Gastrointest Endosc 58 5 (2003) 760-769
5. Reid B.J. Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 20 4 (1991) 817-834
6. Shaheen N., and Ransohoff D.F. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA 287 15 (2002) 1972-1981
7. Rex D.K., Cummings O.W., Shaw M., et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125 6 (2003) 1670-1677
8. Gerson L.B., Shetler K., and Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123 2 (2002) 461-467
9. Sharma D., Reker D., Falk G., et al. Progression of Barrett's esophagus to high-grade dysplasia and cancer: preliminary results of the BEST trial [abstract]. Gastroenterology 120 (2001) 16
10. O'Connor J.B., Falk G.W., and Richter J.E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 94 8 (1999) 2037-2042
11. Drewitz D.J., Sampliner R.E., and Garewal H.S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92 2 (1997) 212-215
12. Provenzale D., Kemp J.A., Arora S., et al. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 89 5 (1994) 670-680
13. American Cancer Society. Cancer facts & figures 2005 (2005), The Society, Atlanta (GA)
14. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER cancer statistics review, 1975-2002 vol. 2005 (2005), National Cancer Institute, Bethesda
15. Winawer S.J., Zauber A.G., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329 27 (1993) 1977-1981
16. Urbach D.R., and Baxter N.N. Does it matter what a hospital is "high volume" for? Specificity of hospital volume-outcome associations for surgical procedures: analysis of administrative data. BMJ 328 7442 (2004) 737-740
17. Bartels H., Stein H.J., and Siewert J.R. Risk analysis in esophageal surgery. Recent Results Cancer Res 155 (2000) 89-96
18. Dimick J.B., Wainess R.M., Upchurch Jr. G.R., et al. National trends in outcomes for esophageal resection. Ann Thorac Surg 79 1 (2005) 212-216 [discussion: 17-8]
19. Lerut T.E., and van Lanschot J.J. Chronic symptoms after subtotal or partial oesophagectomy: diagnosis and treatment. Best Pract Res Clin Gastroenterol 18 5 (2004) 901-915
20. Orringer M.B., Marshall B., and Iannettoni M.D. Eliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis. J Thorac Cardiovasc Surg 119 2 (2000) 277-288
21. Ikeguchi M., Maeta M., and Kaibara N. Respiratory function after esophagectomy for patients with esophageal cancer. Hepatogastroenterology 49 47 (2002) 1284-1286
22. Shibuya S., Fukudo S., Shineha R., et al. High incidence of reflux esophagitis observed by routine endoscopic examination after gastric pull-up esophagectomy. World J Surg 27 5 (2003) 580-583
23. Wolfsen H.C., Hemminger L.L., and DeVault K.R. Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy. BMC Gastroenterol 4 1 (2004) 18
24. Bond J.H. Interference with the adenoma-carcinoma sequence. Eur J Cancer 31A 7-8 (1995) 1115-1117
25. Castleman B., and Krickstein H.I. Do adenomatous polyps of the colon become malignant?. Nord Hyg Tidskr 267 (1962) 469-475
26. Rex D.K., Johnson D.A., Lieberman D.A., et al. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 95 4 (2000) 868-877
27. Ganz R.A., Utley D.S., Stern R.A., et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 60 6 (2004) 1002-1010
28. Sharma D., Overholt B., Wang K., et al. A randomized multi-center evaluation of ablation of nondysplastic short segment Barrett's esophagus using BARRX bipolar balloon device: extended follow-up of the Ablation of Intestinal Metaplasia (AIM-I) Trial [abstract]. Gastrointest Endosc 61 5 (2005) 239
29. Sharma V.K., McLaughlin R., Dean P., et al. Successful ablation of Barrett's esophagus with low-grade dysplasia using BARRX bipolar balloon device: Preliminary results of the Ablation of Intestinal Metaplasia with LGD (AIM-LGD) Trial [abstract]. Gastrointest Endosc 61 5 (2005) 143
30. Dunkin B.J., Martinez J., Bejarano P.A., et al. Thin layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc 20 1 (2006) 125-130
31. Smith C.D., Dunkin B.J., Bejarano P.A., et al. Thin-layer ablation of intestinal metaplasia with high-grade dysplasia in esophagectomy patients using a bipolar radiofrequency balloon device (BARRX System) [abstract]. Gastroenterology 128 4 (2005) 809
32. Fleischer D.E., Sharma V.K., Reymunde A., et al. A prospective multi-center evaluation of ablation of non-dysplastic Barrett's esophagus using the BARRX bipolar balloon device [abstract]. Ablation of Intestinal Metaplasia Trial (AIM-II). Gastroenterology 128 4 (2005) 236
33. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 4 (2005) 488-498
34. Wang K. Photodynamic therapy made simple. Clin Perspect Gastroenterol (2001) 90-100
35. Webber J., Herman M., Kessel D., et al. Current concepts in gastrointestinal photodynamic therapy. Ann Surg 230 1 (1999) 12-23
36. Kubba A.K. Role of photodynamic therapy in the management of gastrointestinal cancer. Digestion 60 1 (1999) 1-10
37. Prosst R.L., Wolfsen H.C., and Gahlen J. Photodynamic therapy for esophageal diseases: a clinical update. Endoscopy 35 12 (2003) 1059-1068
38. DeVault K.R., Ward E.M., Wolfsen H.C., et al. Barrett's esophagus (BE) is common in older patients undergoing screening colonoscopy regardless of gastroesophageal reflux (GER) symptoms [abstract]. Gastrointest Endosc 59 (2004) AB111
39. Wolfsen H.C., and Hemminger L.L. Photodynamic therapy for dysplastic Barrett's esophagus and mucosal adenocarcinoma [abstract]. Gastrointest Endosc 59 5 (2004) AB251
40. Wang K.K., Wong Kee Song L.M., Buttar N.S., et al. Barrett's esophagus after photodynamic therapy: risk of cancer development during long term follow up [abstract]. Gastroenterology 126 Suppl 2 (2004) A50
41. Wang K.K. Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc 49 3 Pt 2 (1999) S20-S23
42. Wolfsen H.C., Woodward T.A., and Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 77 11 (2002) 1176-1181
43. Wang K.K., and Kim J.Y. Photodynamic therapy in Barrett's esophagus. Gastrointest Endosc Clin N Am 13 3 (2003) 483-489 vii
44. Wolfsen H.C. Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett's esophagus. Dig Dis 20 1 (2002) 5-17
45. Overholt B.F., Panjehpour M., and Haydek J.M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 49 1 (1999) 1-7
46. Malhi-Chowla N., Wolfsen H.C., and DeVault K.R. Esophageal dysmotility in patients undergoing photodynamic therapy. Mayo Clin Proc 76 10 (2001) 987-989
47. Ban S., Mino M., Nishioka N.S., et al. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol 28 11 (2004) 1466-1473
48. Vij R., Triadafilopoulos G., Owens D.K., et al. Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 60 5 (2004) 739-756
49. Nijhawan P.K., and Wang K.K. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc 52 3 (2000) 328-332
50. Soetikno R.M., Gotoda T., Nakanishi Y., et al. Endoscopic mucosal resection. Gastrointest Endosc 57 4 (2003) 567-579
51. Conio M., Cameron A.J., Chak A., et al. Endoscopic treatment of high-grade dysplasia and early cancer in Barrett's oesophagus. Lancet Oncol 6 5 (2005) 311-321
52. May A., Gossner L., Behrens A., et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 58 2 (2003) 167-175
53. Haag S., Nandurkar S., and Talley N.J. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointest Endosc 50 2 (1999) 229-240
54. Gossner L., May A., Stolte M., et al. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 49 1 (1999) 8-12
55. Salo J.A., Salminen J.T., Kiviluoto T.A., et al. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg 227 1 (1998) 40-44
56. Bonavina L., Ceriani C., Carazzone A., et al. Endoscopic laser ablation of nondysplastic Barrett's epithelium: is it worthwhile?. J Gastrointest Surg 3 2 (1999) 194-199
57. Barham C.P., Jones R.L., Biddlestone L.R., et al. Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut 41 3 (1997) 281-284
58. Luman W., Lessels A.M., and Palmer K.R. Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus-a pilot study. Eur J Gastroenterol Hepatol 8 7 (1996) 619-630
59. Weston A.P., and Sharma P. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Am J Gastroenterol 97 12 (2002) 2998-3006
60. Ginsberg G.G., Barkun A.N., Bosco J.J., et al. The argon plasma coagulator: February 2002. Gastrointest Endosc 55 7 (2002) 807-810
61. Tigges H., Fuchs K.H., Maroske J., et al. Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus. J Gastrointest Surg 5 3 (2001) 251-259
62. Basu K.K., Pick B., Bale R., et al. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 51 6 (2002) 776-780
63. Morino M., Rebecchi F., Giaccone C., et al. Endoscopic ablation of Barrett's esophagus using argon plasma coagulation (APC) following surgical laparoscopic fundoplication. Surg Endosc 17 4 (2003) 539-542
64. Schulz H., Miehlke S., Antos D., et al. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc 51 6 (2000) 659-663
65. Byrne J.P., Armstrong G.R., and Attwood S.E. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 93 10 (1998) 1810-1815
66. Mork H., Barth T., Kreipe H.H., et al. Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: a prospective study. Scand J Gastroenterol 33 11 (1998) 1130-1134
67. Van Laethem J.L., Cremer M., Peny M.O., et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 43 6 (1998) 747-751
68. Pereira-Lima J.C., Busnello J.V., Saul C., et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol 95 7 (2000) 1661-1668
69. Grade A.J., Shah I.A., Medlin S.M., et al. The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. Gastrointest Endosc 50 1 (1999) 18-22
70. Van Laethem J.L., Jagodzinski R., Peny M.O., et al. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy 33 3 (2001) 257-261
71. Dulai G.S., Jensen D.M., Cortina G., et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc 61 2 (2005) 232-240
72. Montes C.G., Brandalise N.A., Deliza R., et al. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointest Endosc 50 2 (1999) 173-177
73. Sharma P., Sampliner R.E., and Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 92 4 (1997) 582-585
74. Kovacs B.J., Chen Y.K., Lewis T.D., et al. Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest Endosc 49 5 (1999) 547-553
75. Sampliner R.E., Faigel D., Fennerty M.B., et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 53 6 (2001) 554-558
76. Fennerty M.B., Corless C.L., Sheppard B., et al. Pathological documentation of complete elimination of Barrett's metaplasia following endoscopic multipolar electrocoagulation therapy. Gut 49 1 (2001) 142-144
77. Johnston C.M., Schoenfeld L.P., Mysore J.V., et al. Endoscopic spray cryotherapy: a new technique for mucosal ablation in the esophagus. Gastrointest Endosc 50 1 (1999) 86-92
78. Rodgers B.M., McDonald A.P., Talbert J.L., et al. Morphologic and functional effects of esophageal cryotherapy. J Thorac Cardiovasc Surg 77 4 (1979) 543-549
79. Grana L., Ablin R.J., Goldman S., et al. Freezing of the esophagus: histological changes and immunological response. Int Surg 66 4 (1981) 295-301
80. Ackroyd R., Brown N.J., Stephenson T.J., et al. Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed?. J Clin Pathol 52 7 (1999) 509-512
81. Gill K., Nawaz I., Crook J., et al. Variation in Barrett's Esophageal Wall Thickness: Is it associated with histology and length?. Gastrointest Endosc 67 5 (2008) 200 [abstract]
82. Gill K.R., Wolfsen H.C., Preyer N.W., et al. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia. Clin Cancer Res 15 5 (2009) 1830-1836
83. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 360 22 (2009) 2277-2288
84. Bergman J.J. Radiofrequency ablation-great for some or justified for many?. N Engl J Med 360 22 (2009) 2353-2355